Participation of autophagy in the cytotoxicity against breast cancer cells by cisplatin

Oncology Reports

Volumn 34, Issue 1, 2015, Pages 359-367

  Shen, Meng ^a   Duan, Wei Ming ^a   Wu, Meng Yao ^a   Wang, Wen Jie ^a   Liu, Lu ^a   Xu, Meng Dan ^a   Zhu, Jie ^a   Li, Dao Ming ^a   Gui, Qi ^a   Lian, Lian ^a,b   Gong, Fei Ran ^a   Chen, Kai ^a   Li, Wei ^a   Tao, Min ^a,c  

^a SOOCHOW UNIVERSITY   (China)

^b Suzhou Xiangcheng People's Hospital   (China)

^c Institute of Clinical Immunology of Jiangsu Province   (China)

Author keywords

Autophagy; Breast cancer; Chemotherapy; Cisplatin

Indexed keywords

BECLIN 1; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; HISTONE DEACETYLASE 6; METHOTREXATE; 3-METHYLADENINE; ADENINE; ANTINEOPLASTIC AGENT; TAXOID;

AMBRA1 GENE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATG13 GENE; ATG14 GENE; ATG16L2 GENE; ATG3 GENE; ATG4C GENE; ATG4D GENE; ATG5 GENE; ATG7 GENE; AUTOPHAGY; BECLIN1 GENE; BREAST CANCER CELL LINE; CANCER INHIBITION; CONTROLLED STUDY; DRAM1 GENE; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RESPONSE; GABARAP GENE; GABARAPL1 GENE; GABARAPL2 GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HDAC6 GENE; HUMAN; HUMAN CELL; IRGM GENE; MAPILC3B GENE; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ULK1 GENE; UPREGULATION; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; TUMOR CELL LINE;

ADENINE; ANTINEOPLASTIC AGENTS; AUTOPHAGY; BREAST NEOPLASMS; CELL LINE, TUMOR; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METHOTREXATE; TAXOIDS;

EID: 84930034478     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4005     Document Type: Article

References (29)

1. Sasco AJ, Kaaks R and Little RE: Breast cancer: Occurrence, risk factors and hormone metabolism. Expert Rev Anticancer Ther 3: 546-562, 2003.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
3. Tan AA, Mu AK, Kiew LV and Chen Y: Comparative secretomic and N-glycoproteomic profiling in human MCF-7 breast cancer and HMEpC normal epithelial cell lines using a gel-based strategy. Cancer Cell Int 14: 120, 2014.
4. Carlson RW and McCormick B: Update: NCCN breast cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 3 (Suppl 1): S7-S11, 2005.
5. Chen K, Shou LM, Lin F, Duan WM, Wu MY, Xie X, Xie YF, Li W and Tao M: Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells. Anticancer Drugs 25: 652-662, 2014.
6. Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, Peng J, Mi N, Zhao Y, Liu Z, Wan F, et al: Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 465: 942-946, 2010.
7. Li W, Xie L, Chen Z, Zhu Y, Sun Y, Miao Y, Xu Z and Han X: Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis. Cancer Sci 101: 1226-1233, 2010.
8. Yu HC, Lin CS, Tai WT, Liu CY, Shiau CW and Chen KF: Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J Biol Chem 288: 18249-18259, 2013.
9. Chen Y, Azad MB and Gibson SB: Methods for detecting autophagy and determining autophagy-induced cell death. Can J Physiol Pharmacol 88: 285-295, 2010.
10. Sheen JH, Zoncu R, Kim D and Sabatini DM: Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 19: 613-628, 2011.
11. Capparelli C, Chiavarina B, Whitaker-Menezes D, Pestell TG, Pestell RG, Hulit J, Andò S, Howell A, Martinez-Outschoorn UE, Sotgia F, et al: CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, 'fueling' tumor growth via paracrine interactions, without an increase in neoangiogenesis. Cell Cycle 11: 3599-3610, 2012.
12. Plaimee P, Weerapreeyakul N, Barusrux S and Johns NP: Melatonin potentiates cisplatin-induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells. Cell Prolif 48: 67-77, 2015.
13. Yang ZJ, Chee CE, Huang S and Sinicrope FA: The role of autophagy in cancer: Therapeutic implications. Mol Cancer Ther 10: 1533-1541, 2011.
14. Carew JS, Kelly KR and Nawrocki ST: Autophagy as a target for cancer therapy: New developments. Cancer Manag Res 4: 357-365, 2012.
15. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M and Kim DH: ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 20: 1992-2003, 2009.
16. FU LL, Cheng Y and Liu B: Beclin-1: Autophagic regulator and therapeutic target in cancer. Int J Biochem Cell Biol 45: 921-924, 2013.
17. Wang W, Fan H, Zhou Y, Duan P, Zhao G and Wu G: Knockdown of autophagy-related gene BECLIN1 promotes cell growth and inhibits apoptosis in the A549 human lung cancer cell line. Mol Med Rep 7: 1501-1505, 2013.
18. Negri T, Tarantino E, Orsenigo M, Reid JF, Gariboldi M, Zambetti M, Pierotti MA and Pilotti S: Chromosome band 17q21 in breast cancer: Significant association between beclin 1 loss and HER2/NEU amplification. Genes Chromosomes Cancer 49: 901-909, 2010.
19. Pattingre S, Espert L, Biard-Piechaczyk M and Codogno P: Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90: 313-323, 2008.
20. Tanida I, Ueno T and Kominami E: In vitro assays of lipidation of mammalian Atg8 homologs. Curr Protoc Cell Biol 64: 11.20:11.20.1-11.20.13, 2014.
21. Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, et al: Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383-1435, 2010.
22. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T and Ryan KM: DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121-134, 2006.
23. Yang Z and Klionsky DJ: Mammalian autophagy: Core molecular machinery and signaling regulation. Curr Opin Cell Biol 22: 124-131, 2010.
24. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51-64, 2006.
25. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809-1820, 2003.
26. Debnath J: The multifaceted roles of autophagy in tumors-implications for breast cancer. J Mammary Gland Biol Neoplasia 16: 173-187, 2011.
27. Roy S and Debnath J: Autophagy and tumorigenesis. Semin Immunopathol 32: 383-396, 2010.
28. Bao XX, Xie BS, Li Q, Li XP, Wei LH and Wang JL: Nifedipine induced autophagy through Beclin1 and mTOR pathway in endometrial carcinoma cells. Chin Med J 125: 3120-3126, 2012.
29. Zhu BS, Xing CG, Lin F, Fan XQ, Zhao K and Qin ZH: Blocking NF-kappaB nuclear translocation leads to p53-related autophagy activation and cell apoptosis. World J Gastroenterol 17: 478-487, 2011.